HRMY Harmony Biosciences Holdings, Inc.
$39.36 -1.40%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
-1.40%
YTD
+45.50%
P/E
12.73
P/B
2.48
ROE
20.1%
Div yield
—
Beta
0.52
Market cap
$2.3B
RSI (14)
43
Next earnings
Nov 2, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$40.09
Close
$39.36
VWAP (n/a)
—
Day high
$40.35
Day low
$38.91
Volume
507K
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
HRMY vs. CSLLY: Which Stock Is the Better Value Option?
Yahoo Finance · Oct 6
Is Harmony Biosciences (HRMY) Stock Undervalued Right Now?
Yahoo Finance · Oct 6
Why Is Harmony Biosciences (HRMY) Up 12.1% Since Last Earnings Report?
Yahoo Finance · Sep 3
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
Yahoo Finance · Sep 3
Harmony Biosciences Highlights Record WAKIX Growth, Advances Orexin and Epilepsy Pipeline
Yahoo Finance · Aug 14
Harmony Biosciences (HRMY) Q2 2026 Earnings Call Transcript
Yahoo Finance · Aug 11
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Aug 4, 2026 View → 8-K Aug 4, 2026 View → 8-K Jul 16, 2026 View → 8-K May 14, 2026 View → 8-K May 7, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell HRMY. Try it in the Lab to size a position and see the risk.